Status:
UNKNOWN
Proper Dosage of Ketamine in Intravenous Regional Anesthesia
Lead Sponsor:
University Health Network, Toronto
Conditions:
Pain.
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Ketamine added to Lidocaine can increase duration of pain relief following intraveonous regional anesthesia (IVRA). The purpose of this dose response study is to determine the minimum effective dosage...
Eligibility Criteria
Inclusion
- Age: 18-70
- Weight: 50-100 kg
- ASA: I, II, III
- Carpal tunnel syndrome surgery, tenolysis, ganglion removal or any peripheral hand surgery that can be done by IVRA.
Exclusion
- Contraindication to IVRA such as sickle cell disease.
- Any known hypersensitivity reaction to Ketamine.
- History of chronic pain or regular medication with analgesics.
- History of opioid dependence.
- Drug of alcohol abuse.
- Psychiatric disorder.
- Allergy to acetaminophen or codeine
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
January 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00221871
Start Date
January 1 2004
End Date
January 1 2005
Last Update
October 11 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5T2S8